SCHOTT AG, German specialty glass (Carl-Zeiss-Stiftung Foundation private), has faced multiple US class actions over alleged inadequate disclosure of pharmaceutical glass packaging customer demand changes at SCHOTT Pharma 2023 IPO subsidiary, plus periodic European customer warranty claims affecting institutional creditor governance complexity.